GS16a - Mechanical and Chemical Embolization Agents 

GS09d - Debate: Never Perform Thermal and Chemical Ablation in the Same Setting 

GS04d - Debate: Air-based Foam is Satisfactory: Look at the Evidence 

GS04e - Results of Polidocanol Endovenous Microfoam Phase II U.S. Trial: How Close Are We to FDA Approval of a Commercial Foam Preparation? What Impact Will it Have? 

GS04f - Tumescentless Endovenous Ablation: Is There Something New on the Horizon? Will This Affect Thermal Ablation Procedures? 

GS07b - Placing Botulinum Toxin and Dermal Fillers 

GS07c - Other Services: Rejuvenation Procedures 

GS13b - Perforator Treatment: UGS Versus RF Versus Laser: Pros and Cons of Each Technique 

GS14a - Performing Sclerotherapy Effectively 

GS14b - Use of Different Gases for Foam Sclerotherapy 

GS14d - Sclerosants: Importation, Compunding, Off-label Use, Liability 

GS18h - Interpreting Your Medicare Local Coverage Determination (LCD): Items We Should Know: Can We Bill for Foam, It’s Off-label, But Acknowledged to be Effective in the LCD Policy?